chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This case was reported by a nurse via call center representative and described the occurrence of influenza-like symptoms in a adult female patient who received SHINGRIX. On an unknown date, the patient received SHINGRIX .5 ml. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced influenza-like symptoms, difficulty breathing and mobility decreased. On an unknown date, the outcome of the influenza-like symptoms and difficulty breathing were unknown and the outcome of the mobility decreased was recovered/resolved. It was unknown if the reporter considered the influenza-like symptoms, difficulty breathing and mobility decreased to be related to SHINGRIX. Additional details were reported as follows: This case was reported by the patient's friend. The age at vaccination was not reported. The patient experienced terrible flu like symptoms and could not raise her arm for two days. The patient also had difficulty breathing. This information was communicated while the reporter was reporting her own adverse events with the product. The reporter was transferred to Medical Information for additional assistance. This case was linked to the case US2018071812, reported by the same reporter.
Patient came to pharmacy  today complaining of soreness in her left arm after getting the shot. She states this has been going on for weeks after the shot.
the 2nd dose of Moderna vaccine was given beyond the scheduled appointment; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (the 2nd dose of Moderna vaccine was given beyond the scheduled appointment) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (the 2nd dose of Moderna vaccine was given beyond the scheduled appointment). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (the 2nd dose of Moderna vaccine was given beyond the scheduled appointment) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment details were provided.
PATIENT RECEIVED COVID VACCINE AT 0900. AT 0915, PATIENT FELT LIGHT HEADED OUT OF SORTS. VS CHECKED. PATIENT'S VITALS WERE AS FOLLOWS: BP136/86,HR 120. @0916 50MG IM BENADRYL ADMINISTERED X1 DOSE. VS AT 0935: bp 140/88 HR112. DR. CALLED AT 0938 AND WAS MADE AWARE OF THE INCIDENT. DR.'S GUIDANCE WAS TO HAVE THE PATIENT REMAIN IN THE PARKING LOT UNTIL HR WAS LESS THAN 100. AT 1012, PATIENT'S HR WAS 88. @1051, PATIENT LEFT WITH FAMILY MEMBER.
Hypertension; High blood pressure condition has worsened; Weakness; Difficulty to move at night; This spontaneous case was reported by a consumer and describes the occurrence of HYPERTENSION (Hypertension), CONDITION AGGRAVATED (High blood pressure condition has worsened), ASTHENIA (Weakness) and MOBILITY DECREASED (Difficulty to move at night) in an 86-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029K20A and 039K20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension and Parkinson's disease.   On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Feb-1900, the patient experienced MOBILITY DECREASED (Difficulty to move at night). On 04-Feb-2021, the patient experienced HYPERTENSION (Hypertension), CONDITION AGGRAVATED (High blood pressure condition has worsened) and ASTHENIA (Weakness). At the time of the report, HYPERTENSION (Hypertension), CONDITION AGGRAVATED (High blood pressure condition has worsened), ASTHENIA (Weakness) and MOBILITY DECREASED (Difficulty to move at night) outcome was unknown.            Action taken with mRNA-1273 in response to the events was not Applicable.  Concomitant product use was not provided by the reporter. Treatment information was not provided.
Injection given at 11:35am on 1/7/21 in arm- pt went to sit in chair in waiting area- at 11:40 she was seen to bee breathing heavy and pale. She has a history of anxiety BP 90/55 and pulse thready unable to obtain full pulse. She was talking and conscious. Tried to slow breathing she did have stiff cramping fingers due to the hyperventilation. We had her re-breath into a paper box and her cramping of hands and breath improved. She was given juice and BP at 11:50am was 100/60 pulse 80 and not thready. Color improved. She walked out of the clinic feeling better with her mother.
pt experienced SOB and was seen by pcp and referred to ER where evaluation identified PE and DVT of There is deep venous thrombosis present within the left popliteal vein which is nonocclusive and may be acute on chronic. Acute appearing deep venous thrombosis is present within both of the left posterior tibial veins which is occlusive. Likely acute deep venous thrombosis is present within the proximal aspect of a left peroneal vein focally.
Slightly sore arm 24 hours after getting the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Slightly sore arm 24 hours after getting the vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE PAIN (Slightly sore arm 24 hours after getting the vaccine). At the time of the report, VACCINATION SITE PAIN (Slightly sore arm 24 hours after getting the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The concomitant medications and treatment details were not provided.   Most recent FOLLOW-UP information incorporated above includes: On 15-Apr-2021: Follow-up information received on 15-Apr-2021 included email ID,  onset latency of the event slightly sore arm 24 hours after getting the vaccine.
Very sore arm, fever, headache, chills and nausea. On Wed 27th at 3pm, I started alternating taking  Tylenol 500mgs (2 Tabs) and Motrin 400 mgs Today Jan 28: Fever and nausea has been relieved. Still have slight headache and chills
Mother called clinic on 1/24/01 complaining of child having a fever of 102F to 103F and a headache since his fever not relieved by Motrin. Doctor in clinic today, instructed to take child to PMD now for evaluation with copy of shot record including vaccines given on 1/23/01.
This spontaneous report was received from a medical assistant refers to multiple unspecified patients of unknown gender and age. Information regarding patients' medical history, concurrent condition, drug reactions/allergies and concomitant therapy were not provided. On unknown dates, the patients stated the HPV vaccine series GARDASIL and finished the series with GARDASIL 9 (inappropriate schedule of drug administration). No adverse effects were reported. Additional information has been requested.
Initial report received on 31 August 2012 from the Investigator participating in the post-marketing study under the reference number M5A16. A case of pertussis disease in a two-year-old female subject was identified by the investigator based on review of data from the Electronic Disease Surveillance (EDSS) electronic database. The subject had received 3 doses of PENTACEL; lot number C3542AA received on 01 March 2012, C3579AA received on 30 April 2010 and C3608AA received on 06 July 2010 and 1 dose of DAPTACEL; lot number C3618AA received on 13 April 2011 (routes and sites of administration not reported). The subject developed cough and cold-like symptoms on 09 July 2012, approximately 15 months after the last dose. On 14 July 2012, the subject developed a paroxysmal cough without a whoop. The subject also experienced apnea and sleep disturbance. Laboratory testing included positive PCR on 19 July 2012. Chest x-ray findings were negative for pneumonia. Corrective treatment consisted of azithromycin starting on 19 July 2012 for unknown duration. The subject was not hospitalized. At the time of final contact on 23 July 2012, the subject's cough was still persisting. The duration of the cough was reported at that time as 14 days. According to the investigator, this case was epidemiologically linked to a laboratory confirmed case. Investigator causality assessment is not required as per protocol. Documents held by sender: None.
Severe myalgias posterior neck, thoracic and lumbar; clear coryza, sneezing X 1 week.
Pt developed herpes zoster on 10/11/00 on right arm and neck.
Arm stiffness and pain at and around injection site, pain level "20/10." Pain persisted throughout the night and into the next morning, when patient went to PCP. Could not lift arm beyond 90 degrees. Patient used NSAIDs, antihistamines, cold compress (heating pad later) with minimum relief. PCP prescribed Prednisone tablets and patient received Prednisone shot, pain has lessened but still present.
Administered dose 1 Moderna 026L20A 1/22/2021 Administered dose 2 Pfizer EL1284 2/23/2021, instead of Moderna dose 2..  Patient sat on Pfizer side instead of Moderna side.   Observed for 30 minutes. Closely monitored with no adverse side effects reported.
First dose - I got severe headaches for 3 days and also got abdominal cramps also for 3 days Second dose -  Headache, tiredness, chills, nausea, fever, muscle aches lasted 1 1/2 days 2 days after second dose had swelling of lymph nodes on left side and I still have it as of 4/29/21 ( shot on left arm )
Patient states chills occurred few hours after injection on 2/19/03, continued through 2/20/03.  States "knott" appeared on Rt. shoulder.  Saw MD on 2/21/03 with headache, chills, weakenss, sore throat, placed on po ampicillin, admitted to hospital 2/24/03 for c/o shortness of breath, weakness, possible vaccine reaction.
PT's father reports that the day of GARDASIL, pt had subjectively high fever, generalized erythema on forearms and flat, splotchy facial erythema with itch. No op Sx's nor SOB. Resolve by next day. Father contributed above to part of the acute gastroenteritis (AGE) that pt and family were recovering from. Given that we cannot know for certain if constellation of symptoms are from the AGE or vaccine, will defer booster.
Fatigue/Tiredness; Chills; Muscle tiredness; Got dose of Trumenba accidentally; This is a spontaneous report from a non-contactable consumer (mother). An 11-year-old male patient received meningococcal group b rlp2086 (TRUMENBA suspension for injection, lot number and expiration date not reported) via an unspecified route of administration on an unspecified date as single dose for immunization. The patient's medical history and concomitant medications were not reported. The mother reported that her son (patient who was 11years old) got dose of meningococcal group b rlp2086 accidentally and was asking what will happen to her son. The mother also reported that her son (patient) reported fatigue, chills and muscle tiredness, tiredness. The mother was asking if her son should get a second or third dose and when, since her son got a dose of meningococcal group b rlp2086 accidentally. The mother was asking what to do. The mother stated that a doctor told them to wait till her son was 16 and then get vaccinated with meningococcal group b rlp2086. The HCP was aware that the vaccine was given by mistake. The outcome of the events was unknown.  No follow-up attempts are possible, information about batch number cannot be obtained. No further information is expected.
Fussy; Approx 20 sec seizure with no post Ictal state.
3 days after vaccine I woke up with shingles on my left hip and wrapped around to spine.  Doctor treated with Valtrex and Neurontin. Remained on these meds through second dose of vaccine and shingles continued to flare up.   I already had shingles back in 2012 and I am concerned this was a reaction to the vaccine.  I am being screened (in August) for Psoriatic Arthritis.   *** Please note I received my vaccines at  Hospital on .  We then retired and moved to   in April which  is why I now have an  address. I had not reported this earlier as we were in the middle of an inter state move.  I am still experiencing some issues from the left over irritation of the shingles on my hip ( the lesions are gone).  I understand irritation can remain with shingles long after lesions are gone. That seems to be my case
The day before the injection, I drank a lot of water. The morning of the injection, I continued drinking water. I ate a large breakfast of 2 eggs, wontons, and broccoli.  At 10:45 AM, I walked one block to the Pharmacy inside Store. After the injection, I walked around the store. 15 minutes after the injection, I felt dizzy and nearly passed out. The pharmacist brought me a chair and helped me in to it. I asked for water and drank it.  Firemen and a paramedic were called and took vital signs. All was normal except blood pressure was 90/60 which indicates low blood pressure. A fireman said I looked flushed. Later readings showed that blood pressure was back to normal. I was not allowed to walk one block home but had to call for a ride. The rest of the day, I felt better but my head hurt. Today, the next day after the injection, I am fine.
Vertigo; very dry nasal; Stuffy nasal congestion; Severe chills; Body aches particularly in upper back and neck; Fatigue; Fever; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 13Apr2021 at 09:00 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Other medical history included aneurysm of ascending aorta and depression. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 23Mar2021 at 11:30 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. The patient received unspecified other medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 02:30, the patient experienced severe chills, body aches particularly in upper back and neck, fatigue and fever. On 15Apr2021, the patient experienced very dry, stuffy nasal congestion. On 16Apr2021, after woke up, the patient experienced vertigo. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the reported event(s) which included treatment with unspecified medication. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events of severe chills, body aches particularly in upper back and neck, fatigue and fever was recovered on an unknown date in Apr2021 (lasted for 24 hours), while the outcome of the events of  very dry nasal, stuffy nasal congestion and vertigo was not recovered at the time of this report.  No follow-up attempts are possible. No further information is expected.
Left arm soreness 24 hours post injection (minimal) that improved within 48 hours.  Supraclavicular lymph node (left side- mildly tender), left sided neck pain, and left forearm tenderness that began almost 72 hours post vaccine.  No fever.  No other symptoms
Patient passed out within a minute of receiving Janssen Vaccine. She was hypotensive (BP 99/48), pupils dilated, and began twitching. EMS was called and evaluated patient. EMS determined the patient did not need to be transported to the ER via ambulance and the patient's roommate was called to pick her up.
Hives all over his body including his scalp; itching; This case was reported by a consumer via call center representative and described the occurrence of hives in a 81-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included blood pressure high. Concomitant products included losartan.   On 24th February 2020, the patient received the 1st dose of Shingrix (intramuscular). On 27th February 2020, 3 days after receiving Shingrix, the patient experienced hives and pruritus. On 1st March 2020, the outcome of the hives and pruritus were recovered/resolved.   It was unknown if the reporter considered the hives and pruritus to be related to Shingrix.  Additional details were reported as follows: The patient received 1st dose of vaccine in right arm. The patient experienced hives all over his body including his scalp and itching. No other information was reported. The reporter consented to follow up.
3 weeks after the second covid shot I started getting abnormal heart beats with heavy palpitations. As weeks progressed symptoms changed. I started getting chest pain, stinging and burning senstations throughout my body. Leg pain and numbness in my legs, arms, and hands. As months progressed I started getting burning sensations in my head, with weird neurological headaches. I also wasn't able to swallow at times and my mouth would get dry. I would also get brain fog and hard to focus at times. I would get dissy if I turned and focused. Almost 6 months in and I'm still not recovered. I still have heart palpitations, and abnormal heart beats. Weird headaches and burning sensations througout my body with chest pain at times.
This case was reported by a consumer and described the occurrence of exacerbation of asthma in an 11-year-old male subject who was vaccinated with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed (Boostrix, GlaxoSmithKline) for prophylaxis.  A physician or other health care professional has not verified this report.  Concurrent medical conditions included allergy induced asthma.  Concurrent medications included Fluticasone propionate (Flovent) and Salbutamol sulphate (Albuterol).  Other unknown vaccinations were given on the same date as Boostrix (March 2007).  In March 2007 the subject received 1st dose Boostrix (unknown arm).  In November 2007, approximately 8 to 9 months after vaccination with Boostrix, the subject's asthma worsened.  On 24 November 2007, he also developed a slight fever and coughing that becomes so bad that he vomited and could not sleep.  The reporter also noted that on an unspecified date in November 2007, the subject developed classic whooping cough symptoms.  The subject was tested for whooping cough on 06 December 2007 and the results were pending at the time of the report.  The reporter noted that she is concerned that the vaccine was not effective and that he has whooping cough.  The subject was seen in the emergency room at an unspecified time.  This case was assessed as medically serious by GSK.  At the time of reporting the fever had resolved and the outcome of the other events were unspecified.
pt recv vax 18APR97 & & 21APR97 pt exp polyarthralgias starting in lt ankle described as a burning pain that woke pt up;taken to ER 21APR97;tx w/med;elevated sed rate;dx reactive arthritis believed to be r/t vax;rash, fever, warm joints;
02/22/2021- My left leg started to swell and was uncomfortable and by 02/24/2021 it had worsened, therefore i went to the emergency room and was advised to start taking a full dose aspirin once a day. I was given a support stocking to help with the swelling. A week later it was diagnosed with Lymphedema and having to wear a support stocking everyday.
nearly passed out; the shoulder where she got her injection started hurting really bad; getting hot; sweating; thirsty; Her blood pressure dropped; couldn't breathe; arm hurting really bad; got very weak; turned gray, like an elephant; felt floaty; This is a spontaneous report from a contactable consumer (patient).   A 51-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration at left shoulder (Arm Left) on 19Apr2021 10:00 AM at age of 51 years old (Batch/Lot number was not reported) as 1ST, SINGLE for covid-19 immunisation.  The patient's medical history was reported as just told her blood pressure dropped on an unknown date, hooked patient up to a bunch of wires and stomach, monitoring her on a machine. The last couple of time patient had blood drawn, the one last time, she went into shock and passed out. This wasn't quite the same thing with this time. This was maybe 2 years before unspecified date. One time it was pretty bad and patient fell down, get the doctor and hook patient up to all that stuff. Didn't' quite feel the same way as this time. She didn't get hot and sweaty. Patient was not taking any pills. The concomitant medications were not reported. After first dose of the Pfizer covid vaccine.  After the injection on 19Apr2021, patient sat for 15 minutes (wait for 15 minutes) and the shoulder where she got her injection started hurting really bad. Arm hurting really bad, walked across the hall and sat in the chair, maybe 2 minutes later. Then started tearing her mask off because she couldn't breathe.  Patient started getting hot, sweaty and thirsty. Patient was sweating, started getting hot and thristy and then got really sweaty and super hot. Got really thirsty and was given water. She was trying to grab a bottle of water and she didn't have the strength. She got very weak, turned gray, like an elephant and her blood pressure dropped, and nearly passed out. It lasted maybe 10 or 15 minutes. They called the ambulance. By the time they got there, she was feeling more back within herself and It was pretty much done and was totally better, maybe 90 percent. She just wanted to go home and did not go in the ambulance.  She felt floaty but did not pass out. With the first one, she had a reaction and is wondering if she should even take the second one. Therapeutic measures were taken as a result of thirsty included water. Treatment for other event was reported as none, and she was not taking any medication. The event outcome of recovered on 19Apr2021.  Information about lot and batch number was requested.